| Literature DB >> 25317017 |
Jung Hwan Park1, Yong Chul Kim2, Ho Seok Koo3, Se Won Oh4, Suhnggwon Kim5, Ho Jun Chin6.
Abstract
Stomach cancer is one of the most common cancers in Korea. The aim of this study was to identify the association between the prevalence of cancer, particularly stomach cancer, and the amount of 24-hr urine sodium excretion estimated from spot urine specimens. The study included 19,083 subjects who took part in the Korean National Health and Nutritional Examination Survey between 2009 and 2011. The total amount of urine sodium excreted in a 24-hr period was estimated by using two equations based on the values for spot urine sodium and creatinine. In subjects who had an estimated 24-hr urine sodium excretion of more than two standard deviations above the mean (group 2), the prevalence of stomach cancer was higher than in subjects with lower 24-hr sodium excretion (group 1). By using the Tanaka equation to estimate it, the prevalence of stomach cancer was 0.6% (114/18,331) in group 1, whereas it was 1.6% (9/568) in group 2 (P=0.006). By using the Korean equation, the prevalence was 0.6% (115/18,392) in group 1, and 1.6% in group 2 (8/507) (P=0.010). By using the Tanaka equation, breast cancer in women is more prevalent in group 2 (1.9%, 6/324) than group 1 (0.8%, 78/9,985, P=0.039). Higher salt intake, as defined by the estimated amount of 24-hr urine sodium excretion, is positively correlated with a higher prevalence of stomach or breast cancer in the Korean population.Entities:
Keywords: 24-Hour Urine Sodium; Cancer; Spot Urine Sodium
Mesh:
Substances:
Year: 2014 PMID: 25317017 PMCID: PMC4194283 DOI: 10.3346/jkms.2014.29.S2.S131
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153
Fig. 1The prevalence of stomach cancer defined by medical history according to the estimated dietary sodium intake. Group 1: dietary sodium intake of ≤ 2.140 g/day. Group 2: dietary sodium intake, 2.14-4.910 g/day. Group 3: dietary sodium intake, 4.911-9.200 g/day. Group 4: dietary sodium intake of ≥ 9.201 g/day. All: all participants with stomach cancer history. Present: participants with current stomach cancer. Recent: participants with stomach cancer diagnosed within 5 yr.
The prevalence of stomach cancer defined by history according to the estimated 24-hr urine sodium excretion level
E24UNA_T: estimated 24-hr urine sodium with the equation proposed by Tanaka et al. E24UNA_K: estimated 24-hr urine sodium with the equation proposed in this study. Group 1: E24UNA of ≤71.0 mEq/day for TANAKA; E24UNA of ≤95.0 mEq/day for KOREA. Group 2: E24UNA, 71.01-144.0 mEq/day for TANAKA; E24UNA, 95.1-167.0 mEq/day for KOREA. Group 3: E24UNA, 144.1-261.0 mEq/day for TANAKA; E24UNA, 167.1-240.0 mEq/day for KOREA. Group 4: E24UNA of ≥261.1 mEq/day for TANAKA; E24UNA of ≥240.1 mEq/day for KOREA. All: all of participants with stomach cancer history. Present: participants with current stomach cancer. Recent: participants with stomach cancer diagnosed within 5 yr. P value for All stomach cancer by E24UNA_T=0.015. P value for All stomach cancer by E24UNA_K=0.027. P value for All stomach cancer between Group 1-3 and Group 4 by E24UNA_T=0.013. P value for All stomach cancer between Group 1-3 and Group 4 by E24UNA_K=0.019.
Fig. 2The prevalence of stomach cancer defined by medical history according to estimated 24-hr urine sodium excretion. E24UNA_TANAKA: estimated 24-hr urine sodium excretion estimated by using the equation proposed by Tanaka et al. E24UNA_KOREA: estimated 24-hr urine sodium excretion estimated by using the equation described in this study. Group 1: E24UNA of ≤ 71.0 mEq/day for TANAKA; E24UNA of ≤ 95.0 mEq/day for KOREA. Group 2: E24UNA, 71.01-144.0 mEq/day for TANAKA; E24UNA, 95.1-167.0 mEq/day for KOREA. Group 3: E24UNA, 144.1-261.0 mEq/day for TANAKA; E24UNA, 167.1-240.0 mEq/day for KOREA. Group 4: E24UNA of ≥ 261.1 mEq/day for TANAKA; E24UNA of ≥ 240.1 mEq/day for KOREA.
Multivariable logistic regression analysis for the detection of the factors related to the history of stomach cancer
95% CI for OR: 95% confidence interval for the odds ratio. E24UNA_K: a continuous variable of the estimated 24-hr urine sodium excretion in 100 mEq/day unit, calculated with the equation created in this study. E24UNA_K2: a group of E24UNA_K stratified with a criterion of 240 mEq/day. E24UNA_K2 (high): participants with ≥241 mEq/day of E24UNA_K. E24UNA_T: a continuous variable of estimated 24-hr urine sodium in 100 mEq/day unit, calculated with the equation created by Tanaka et al. E24UNA_T2 (high): participants with ≥261 mEq/day, as calculated by using the E24UNA_T model. Model 1: logistic regression for the presence of stomach cancer adjusted for age and sex. Model 2: adjusted for age, sex, and smoking and drinking habits. Model 3: adjusted for age, sex, smoking and drinking habits, grade of household income, marital status, employment status, grade of education-year, history of ischemic heart disease, colon cancer, lung cancer, presence of diabetes mellitus, hypertension, and chronic kidney disease at the time of the survey.
The characteristics of participants grouped according to history of stomach cancer
E24UNA_T: a continuous variable of estimated 24-hr urine sodium, calculated with the equation created by Tanaka et al., E24UNA_K: a continuous variable of estimated 24-hr urine sodium, calculated with the equation created in this study, Household income: Quartile group of household income defined by the Korean government according to number of household members. BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure; CKD, chronic kidney disease.
Overall characteristics of participants in this study
Completeness: completeness of data among participants, E24UNA_T: estimated value of 24-hr urine sodium amount with the equation proposed by Tanaka et al., E24UNA_K: estimated value of 24-hr urine sodium amount with the equation proposed by this study. Mean-2SD: value of mean of E24UNA subtracted by 2×the standard deviation of E24UNA. Mean+2SD: value of mean of E24UNA plus 2×the standard deviation of E24UNA. Diagnosed year: time difference between current age and the age at diagnosis (yr). Present illness: participants with an illness at the time of the survey. Recent cancer: participants with cancer diagnosed within 5 yr.